.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
UBS
Fish and Richardson
Deloitte
Cipla
Covington
Accenture
Fuji
Merck
Julphar

Generated: December 16, 2017

DrugPatentWatch Database Preview

Oxazepam - Generic Drug Details

« Back to Dashboard

What are the generic sources for oxazepam and what is the scope of oxazepam patent protection?

Oxazepam
is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Am Therap, Anda Repository, Ivax Sub Teva Pharms, Mylan, Sandoz, Watson Labs, Watson Labs Teva, Alpharma Us Pharms, Quantum Pharmics, Parke Davis, and Sun Pharm Industries, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for oxazepam. Seven suppliers are listed for this compound.

Pharmacology for oxazepam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine

Medical Subject Heading (MeSH) Categories for oxazepam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Anda RepositoryOXAZEPAMoxazepamCAPSULE;ORAL071026-003Aug 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Anda RepositoryOXAZEPAMoxazepamCAPSULE;ORAL071026-001Aug 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Anda RepositoryOXAZEPAMoxazepamCAPSULE;ORAL071026-002Aug 10, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Am TherapOXAZEPAMoxazepamCAPSULE;ORAL071957-001Mar 3, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsOXAZEPAMoxazepamCAPSULE;ORAL070943-001Aug 3, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Am TherapOXAZEPAMoxazepamCAPSULE;ORAL071956-001Mar 3, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Quantum PharmicsZAXOPAMoxazepamCAPSULE;ORAL070641-001Mar 1, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis ElizabethOXAZEPAMoxazepamCAPSULE;ORAL072253-003Apr 14, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsOXAZEPAMoxazepamCAPSULE;ORAL070944-001Aug 3, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis ElizabethOXAZEPAMoxazepamCAPSULE;ORAL072253-001Apr 14, 1988ABRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: oxazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alpharma Us PharmsSERAXoxazepamCAPSULE;ORAL015539-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alpharma Us PharmsSERAXoxazepamCAPSULE;ORAL015539-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alpharma Us PharmsSERAXoxazepamCAPSULE;ORAL015539-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Novartis
Mallinckrodt
AstraZeneca
UBS
Moodys
Medtronic
Colorcon
Fish and Richardson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot